Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis.
Paller AS, de Bruin-Weller M, Marcoux D, Baselga E, Oliveira de Carvalho V, Ardusso LRF, Pasmans SGMA, Toledo-Bahena M, Rubin C, Joyce JC, Wine Lee L, Adams B, Gupta R, Ardeleanu M, Zhang A. Paller AS, et al. Among authors: toledo bahena m. J Am Acad Dermatol. 2025 Feb;92(2):242-251. doi: 10.1016/j.jaad.2024.09.046. Epub 2024 Oct 9. J Am Acad Dermatol. 2025. PMID: 39389429 Free article.
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials.
Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, Gupta P, Proulx J, Lan S, Wolk R; OPT Pivotal 1 and OPT Pivotal 2 investigators. Papp KA, et al. Br J Dermatol. 2015 Oct;173(4):949-61. doi: 10.1111/bjd.14018. Br J Dermatol. 2015. PMID: 26149717 Clinical Trial.
Now that griseofulvin is not available, what to do with tinea capitis treatments?
Bonifaz A, Lumbán-Ramírez P, García-Sotelo RS, Vidaurri de la Cruz H, Toledo-Bahena M, Valencia-Herrera A. Bonifaz A, et al. Among authors: toledo bahena m. Expert Rev Anti Infect Ther. 2024 Dec;22(12):1017-1022. doi: 10.1080/14787210.2024.2405936. Epub 2024 Sep 19. Expert Rev Anti Infect Ther. 2024. PMID: 39297581 Review.
Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil.
Toledo-Bahena ME, Camargo-Sánchez KA, Cruz HV, Valencia-Herrera AM, Ocáriz MMS, Duarte-Abdala MR, Osuna-Osuna J, Aranda-Mendoza J, Rosales-Solís GM, Maza-Ramos G, Orozco-Covarrubias ML, Valle PL, Erdmenger-Orellana JR, Enríquez-García R, Dies-Suárez P, Celis-Jiménez A, Mena-Cedillos CA. Toledo-Bahena ME, et al. Bol Med Hosp Infant Mex. 2024;81(Supl 2):1-28. doi: 10.24875/BMHIM.24000069. Bol Med Hosp Infant Mex. 2024. PMID: 39009029 Free article. English.
Pigmented neurofibroma with hypertrichosis.
Godínez-Chaparro JA, Valencia-Herrera AM, Mena-Cedillos CA, Toussaint-Caire S, Duarte-Abdala MR, Loza-Escutia O, Toledo-Bahena ME. Godínez-Chaparro JA, et al. Among authors: toledo bahena me. Bol Med Hosp Infant Mex. 2023;80(1):57-62. doi: 10.24875/BMHIM.21000197. Bol Med Hosp Infant Mex. 2023. PMID: 36867567 Free article. English.
[Guidelines on atopic dermatitis for Mexico (GUIDAMEX): using the ADAPTE methodology].
Larenas-Linnemann D, Rincón-Pérez C, Luna-Pech JA, Macías-Weinmann A, Vidaurri-de la Cruz H, Navarrete-Rodríguez EM, Del Río-Navarro BE, Godínez-Alderete L, Guevara-Sanginés E, Ortega-Martell JA, Toledo-Bahena ME, Elizondo-Villareal B, Madrigal-Beas IM, Amaya-Guerra M, Barreras-Salcedo JI, Boeta-Ángeles L, Campos-Rivera A, Casillas-Guzmán ME, Duarte-Abdala MR, Espinosa-Padilla SE, García-Rodríguez JC, Gómez-Flores M, Gómez-Mendoza RA, Del C Lacy-Niebla RM, Miranda-Aguirre AI, Olivares-Nolasco C, Onuma-Takane E, Pérez-Luna M, Pliego-Reyes CL, Rodríguez-Aguilera ML, Sáez-de Ocariz-Gutiérrez MDM, Saucedo-Sánchez A, Sotelo-Ocampo AB, Valencia-Herrera AM, Vázquez-García J, Wakida-Kuzunoki GH, Camarillo-Saavedra J, Rodríguez Monroy FA. Larenas-Linnemann D, et al. Among authors: toledo bahena me. Gac Med Mex. 2023 Jan 20;158(Suplement 2):1-116. doi: 10.24875/GMM.M22000690. Gac Med Mex. 2023. PMID: 36763412 Free article. Spanish.
Acne and diet: a review of pathogenic mechanisms.
González-Mondragón EA, Ganoza-Granados LDC, Toledo-Bahena ME, Valencia-Herrera AM, Duarte-Abdala MR, Camargo-Sánchez KA, Mena-Cedillos CA. González-Mondragón EA, et al. Among authors: toledo bahena me. Bol Med Hosp Infant Mex. 2022;79(2):83-90. doi: 10.24875/BMHIM.21000088. Bol Med Hosp Infant Mex. 2022. PMID: 35468121 Free article. Review. English.
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
Paller AS, Seyger MMB, Magariños GA, Pinter A, Cather JC, Rodriguez-Capriles C, Zhu D, Somani N, Garrelts A, Papp KA; IXORA-PEDS Investigators. Paller AS, et al. JAMA Dermatol. 2022 May 1;158(5):533-541. doi: 10.1001/jamadermatol.2022.0655. JAMA Dermatol. 2022. PMID: 35416908 Free PMC article. Clinical Trial.
23 results